Annick Prigent Selected Research

Annick Prigent Research Topics

8	Parkinson Disease (Parkinson's Disease) 09/2022 - 11/2005
3	Parkinsonian Disorders (Parkinsonism) 04/2011 - 06/2003
2	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2009 - 11/2005
1	COVID-19 01/2023
1	REM Sleep Behavior Disorder 09/2022
1	Dementia (Dementias) 11/2021
1	Brain Neoplasms (Brain Tumor) 04/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Dyskinesias (Dyskinesia) 01/2015
1	Inflammation (Inflammations) 04/2011
1	Tauopathies 11/2005
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2005

3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017 - 11/2008
2	alpha-SynucleinIBA 09/2022 - 11/2005
2	tau Proteins (tau Protein)IBA 11/2021 - 11/2005
2	Amyloid (Amyloid Fibrils)IBA 11/2021 - 01/2019
2	Peptides (Polypeptides)IBA 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2003
1	FurinIBA 01/2023
1	SARS-CoV-2 spike proteinIBA 01/2023
1	neuromelaninIBA 09/2022
1	Purinergic P2X7 ReceptorsIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Purinergic Receptors (Receptors, Purine)IBA 01/2019
1	Protease La (Endopeptidase La)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2015
1	GlucocorticoidsIBA 04/2011
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2011
1	Dopamine Agents (Dopaminergic Agents)IBA 08/2010
1	Cholinergic Agents (Cholinergics)IBA 08/2010
1	Dopamine (Intropin)FDA LinkGeneric 01/2009
1	NeurotoxinsIBA 11/2008
1	MetalsIBA 11/2008
1	Oxidopamine (6 Hydroxydopamine)IBA 11/2008
1	IronIBA 11/2008
1	RotenoneIBA 11/2005
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2003

1	Drug Therapy (Chemotherapy) 04/2017